Related Experiment Video
Updated: Aug 9, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Effects of smoking on lipid parameters during therapeutic weight loss
Abstract:
Evaluation of the obesity- and smoking-related atherogenic risk in an obese population, was studied by retrospectively reporting the 6-month dietary effect on metabolic lipoprotein parameters. In a non-smoker group, a weight reduction programme exhibits a marked improvement (P less than 0.05) of HDL and LDL cholesterol and atherogenic index. Smoking during successful, therapeutic weight reduction inhibits this advantageous improvement of lipid parameters, especially in women. In regard to the lipoprotein related vascular risk, obesity treatment without modifying smoking habits is less advantageous.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Stress Prevention and Stress Management Techniques IV

